31. Magic Mushrooms & Psilocybin | Experience, Meaning & the Return of Psychedelics

Send us Fan MailIn this episode of Mohivate, Dr Mohi Sarawgee explores psilocybin, the compound found in magic mushrooms, tracing its journey from ancient sacred ceremony to some of the most rigorous clinical research in psychiatry today.The episode begins where the science begins. With language. When neuroscientists at Johns Hopkins first documented what psilocybin did to the human brain, they had to invent entirely new words to describe it. Ego dissolution. Oceanic boundlessness. Mystical type experience score. This episode explores why those words matter clinically, and what the Default Mode Network has to do with depression, addiction, and the way the brain finds its way back to itself.From Richard Nixon’s 1970 decision to classify psilocybin as a Schedule 1 drug, freezing decades of promising research, to landmark clinical trials, this episode covers the full story honestly. The science on terminal cancer anxiety, treatment resistant depression, addiction, and microdosing is examined carefully - where the evidence is strong, where it is thin, and what regulatory bodies worldwide are now saying.With clinical insight, personal perspective, and a thread that begins with Roald Dahl, this is a conversation about what happens when science refuses to stay buried.References1.The 2006 Johns Hopkins Paper — The One That Changed Everythinghttps://pubmed.ncbi.nlm.nih.gov/16826400/2.Psilocybin in Terminal Cancer Patients — 2016 Landmark Studyhttps://pmc.ncbi.nlm.nih.gov/articles/PMC5367557/3.Psilocybin vs Escitalopram — NEJM 2021https://www.nejm.org/doi/full/10.1056/NEJMoa20329944.Psilocybin and Smoking Cessation — The 80% Studyhttps://pmc.ncbi.nlm.nih.gov/articles/PMC4286320/5.Default Mode Network and Depression — Key Neuroscience Paperhttps://pubmed.ncbi.nlm.nih.gov/24567117/6.Psilocybin and the Default Mode Network — Brain Imaginghttps://www.pnas.org/doi/10.1073/pnas.11195981097.Microdosing — James Fadiman Book Referencehttps://www.amazon.com/Psychedelic-Explorers-Guide-Therapeutic-Journeys/dp/15947740218.Microdosing Blinded Trials — Placebo Effectshttps://elifesciences.org/articles/628789.Psilocybin Safety Profile — The Lancethttps://www.thelancet.com/journals/lancet/article/PIIS0140-6736(10)61462-6/fulltext10.Nixon, Ehrlichman and the War on Drugshttps://edition.cnn.com/2016/03/23/politics/john-ehrlichman-nixon-drug-war-blacks-hippie/index.html11.Australia Approves Psilocybin — TGA 2023https://www.tga.gov.au/news/media-releases/tga-approves-mdma-and-psilocybin-use-ptsd-and-depression-australia-first12.FDA Breakthrough Therapy Designation for Psilocybinhttps://compasspathways.com/compass-pathways-receives-fda-breakthrough-therapy-designation-for-psilocybin-therapy-for-treatment-resistant-depression/13.UK Innovative Licensing and Access Pathway — ILAPhttps://ir.compasspathways.com/News–Events-/news/news-details/2025/Compass-Pathways-Successfully-Achieves-Primary-Endpoint-in-First-Phase-3-Trial-Evaluating-COMP360-Psilocybin-for-Treatment-Resistant-Depression/default.aspx14.Yale Program for Psychedelic Sciencehttps://medicine.yale.edu/psychiatry/research/clinics-and-programs/psychedelic/15.Johns Hopkins Centre for Psychedelic and Consciousness Researchhttps://www.hopkinsmedicine.org/psychiatry/research/psychedelics-research16.Imperial College London Centre for Psychedelic Researchhttps://www.imperial.ac.uk/psychedelic-research-centre17.R. Gordon Wasson — Seeking the Magic Mushroom, Life Magazine 1957https://www.imaginaria.org/wasson/life.htm18.Psilocybin Drug Interactions — Lithium and SSRIshttps://pubmed.ncbi.nlm.nih.gov/18593734/Just a gentle reminder: this episode is for information, education, and inspiration only. It’s not a substitute for your doctor’s advice. For any personal health concerns, always seek guidance from your doctor.